Achieve Life Sciences (STU:SP4P) Moat Score: 2/10 (As of Jul. 11, 2026)


STU:SP4P Achieve Life Sciences Inc STU:SP4P
32 GF Score
Price €5.35
! 4 Warning Signs
View Full Analysis

What is Achieve Life Sciences Moat Score?

Achieve Life Sciences STU:SP4P -3.60% 32 Moat Score is 2 as of Jul. 11, 2026. GuruFocus rates STU:SP4P with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,395 Biotechnology companies, Achieve Life Sciences ranks better than 58.35% on this metric.

Achieve Life Sciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Achieve Life Sciences has No Moat: Achieve Life Sciences Inc has limited market presence and lacks significant intellectual property or patents that provide a competitive edge. The company does not exhibit strong brand loyalty, cost advantages, or regulatory barriers that would contribute to a sustainable moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Achieve Life Sciences might have No Moat - Very weak/transient advantages.

Achieve Life Sciences  (STU:SP4P) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Achieve Life Sciences Moat Score Related Terms

STU:SP4P vs STTK, CRMD, EIKN: Moat Score Comparison

For the Biotechnology subindustry, Achieve Life Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achieve Life Sciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's Moat Score falls into.


STU:SP4P
32GF Score
Achieve Life Sciences Inc STU:SP4P
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Achieve Life Sciences (STU:SP4P) has a Moat Score of 2 as of Jul. 11, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Achieve Life Sciences ranks #581 out of 1395 companies in the Biotechnology industry, placing it in the top 41.6%.
Is Achieve Life Sciences' Moat Score too high?
Achieve Life Sciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Achieve Life Sciences' value of 2 is 0% at this industry median. Based on the distribution chart, Achieve Life Sciences ranks #581 out of 1395 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Achieve Life Sciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Achieve Life Sciences' Moat Score compare to STTK and CRMD?
According to the Biotechnology industry distribution chart, Achieve Life Sciences ranks #581 out of 1395 companies for Moat Score. This puts Achieve Life Sciences in the upper half of its industry. The industry median Moat Score is 2.00. Achieve Life Sciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Achieve Life Sciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Achieve Life Sciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achieve Life Sciences stock overvalued right now?
Achieve Life Sciences (STU:SP4P) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Achieve Life Sciences' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Achieve Life Sciences (STU:SP4P), the current Moat Score is 2 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Achieve Life Sciences Business Description

Other Exchanges ACHV:USASP4P:Germany
Address 22722 29th Drive SE, Suite 100, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
32GF Score

Get the complete analysis for STU:SP4P

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.35
Price